Drawing for XENOTECH

USPTO serial 75108566

XENOTECH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POWERS, ALEXANDER L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XENOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Beth M. Goldman

BETH M GOLDMAN HELLER, EHRMAN, WHITE & MCAULIFFE525 UNIVERSITY AVEPALO ALTO, CA 94301-1900UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, and manufacturing pharmaceuticals; and cell lines for use in the manufacture of pharmaceuticalsACTIVE—
005biochemicals, namely, monoclonal antibodies and fragments thereof for clinical diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseases; and cell lines for clinical diagnostic and therapeutic use for the treatment of cancer, infectious diseases, inflammatory diseases, and genetic diseasesACTIVE—
031animal embryos for laboratory use; and live animals for research and developmentACTIVE—
042pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 5, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 14, 2001EX5GSOU EXTENSION 5 GRANTED—
Oct 30, 2000EXT5SOU EXTENSION 5 FILED—
Jun 29, 2000EX4GSOU EXTENSION 4 GRANTED—
May 3, 2000EXT4SOU EXTENSION 4 FILED—
Jan 2, 2000EX3GSOU EXTENSION 3 GRANTED—
Nov 18, 1999EXT3SOU EXTENSION 3 FILED—
Jun 17, 1999EX2GSOU EXTENSION 2 GRANTED—
May 17, 1999EXT2SOU EXTENSION 2 FILED—
Dec 15, 1998EX1GSOU EXTENSION 1 GRANTED—
Nov 17, 1998EXT1SOU EXTENSION 1 FILED—
May 19, 1998NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 2, 1997ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 4, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 3, 1997NPUBNOTICE OF PUBLICATION—
Jun 16, 1997CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 12, 1997CNEAEXAMINER'S AMENDMENT MAILED—
Jun 4, 1997CNEAEXAMINER'S AMENDMENT MAILED—
Apr 22, 1997CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 1996CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 1996DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance